Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

ClinicalTrials.gov ID: NCT02384941

Public ClinicalTrials.gov record NCT02384941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of LX4211 as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Study identification

NCT ID
NCT02384941
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
793 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Sotagliflozin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2015
Primary completion
Aug 31, 2016
Completion
Jan 31, 2017
Last update posted
Feb 11, 2020

2015 – 2017

United States locations

U.S. sites
63
U.S. states
28
U.S. cities
58
Facility City State ZIP Site status
Lexicon Investigational Site Birmingham Alabama 35294
Lexicon Investigational Site Little Rock Arkansas 72205
Lexicon Investigational Site Escondido California 92025
Lexicon Investigational Site Greenbrae California 94904
Lexicon Investigational Site Huntington Beach California 92648
Lexicon Investigational Site La Jolla California 92037
Lexicon Investigational Site Los Angeles California 90057-3550
Lexicon Investigational Site Orange California 92868
Lexicon Investigational Site Palm Springs California 92262
Lexicon Investigational Site San Mateo California 94401
Lexicon Investigational Site Tarzana California 91356
Lexicon Investigational Site Tustin California 92780
Lexicon Investigational Site Walnut Creek California 94598
Lexicon Investigational Site Aurora Colorado 70045
Lexicon Investigational Site Longmont Colorado 80501
Lexicon Investigational Site Fleming Island Florida 32003
Lexicon Investigational Site Jacksonville Florida 32204
Lexicon Investigational Site Jacksonville Florida 32216
Lexicon Investigational Site New Port Richey Florida 34652
Lexicon Investigational Site Ormond Beach Florida 32174
Lexicon Investigational Site West Palm Beach Florida 33401
Lexicon Investigational Site Atlanta Georgia 30318
Lexicon Investigational Site Lawrenceville Georgia 30046
Lexicon Investigational Site Roswell Georgia 30076
Lexicon Investigational Site Honolulu Hawaii 96814
Lexicon Investigational Site Crystal Lake Illinois 60012
Lexicon Investigational Site Elgin Illinois 60123
Lexicon Investigational Site Springfield Illinois 62711
Lexicon Investigational Site Topeka Kansas 66606
Lexicon Investigational Site Lexington Kentucky 40503
Lexicon Investigational Site Bangor Maine 04401
Lexicon Investigational Site Baltimore Maryland 21204
Lexicon Investigational Site Boston Massachusetts 02215
Lexicon Investigational Site Detroit Michigan 46214
Lexicon Investigational Site Chesterfield Missouri 63017
Lexicon Investigational Site St Louis Missouri 63110
Lexicon Investigational Site Omaha Nebraska 68131
Lexicon Investigational Site Henderson Nevada 89052
Lexicon Investigational Site Las Vegas Nevada 89148
Lexicon Investigational Site Albany New York 12206
Lexicon Investigational Site New York New York 10029
Lexicon Investigational Site Asheville North Carolina 28803
Lexicon Investigational Site Chapel Hill North Carolina 27517
Lexicon Investigational Site Morehead City North Carolina 28557
Lexicon Investigational Site Columbus Ohio 43201
Lexicon Investigational Site Oklahoma City Oklahoma 73112
Lexicon Investigational Site Portland Oregon 97239
Lexicon Investigational Site Greer South Carolina 29651
Lexicon Investigational Site Rapid City South Dakota 57701
Lexicon Investigational Site Chattanooga Tennessee 37404
Lexicon Investigational Site Chattanooga Tennessee 37411
Lexicon Investigational Site Memphis Tennessee 38119
Lexicon Investigational Site Austin Texas 78749
Lexicon Investigational Site Dallas Texas 75230
Lexicon Investigational Site Dallas Texas 75231
Lexicon Investigational Site Dallas Texas 75246
Lexicon Investigational Site Houston Texas 77079
Lexicon Investigational Site Houston Texas 77095
Lexicon Investigational Site San Antonio Texas 78258
Lexicon Investigational Site Schertz Texas 78154
Lexicon Investigational Site Chesapeake Virginia 23321
Lexicon Investigational Site Renton Washington 98057
Lexicon Investigational Site Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02384941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2020 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02384941 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →